Sonata Software announces Q1FY27 results date; earnings call set for Aug 7

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights

Sonata Software Limited has announced it will declare its un-audited financial results for the quarter ended June 30, 2026, on August 6, 2026. The company will hold an earnings conference call on August 7, 2026, from 4:00 p.m. to 5:00 p.m. IST, allowing investors to review Q1FY27 performance and strategic updates. The filing was submitted to NSE and BSE on July 30, 2026, in compliance with SEBI Regulation 30.

powered bylight_fuzz_icon
46978499

*this image is generated using AI for illustrative purposes only.

Sonata Software Limited will announce its un-audited financial results for the quarter ended June 30, 2026, on August 6, 2026. The disclosure marks the release of the company's first-quarter performance for FY27. Management will provide an update on operational metrics and financial health during a subsequent earnings conference call scheduled for August 7, 2026. This schedule allows investors to review the quarterly performance ahead of any broader market reactions to the AI-first modernization engineering firm’s latest financial standing.

The Board of Directors approved the date for the results announcement during its meeting held on Thursday, August 6, 2026. The intimation regarding the schedule for the analysts' and investors' call was issued in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Mangal Kulkarni, Company Secretary, Compliance Officer and Head Legal, and submitted to the National Stock Exchange of India Limited and BSE Limited on July 30, 2026.

Earnings Call Schedule

The earnings conference call is designed to allow investors and analysts to review the quarterly performance and ask questions regarding the company's strategic direction. The session will take place on Friday, August 7, 2026, from 4:00 p.m. to 5:00 p.m. IST. Participants can join via Zoom or through an audio-only dial-in option.

Event Date Time (IST) Platform
Results Announcement August 06, 2026 N/A Company Website
Analysts / Investors Call August 07, 2026 4:00 p.m. – 5:00 p.m. Zoom / Audio Dial-in

Participants connecting via Zoom can view the presentation and raise their hand to ask questions. For those opting for the audio-only connection, pre-registration is required via the provided portal. Upon registration, participants receive a passcode and dial-in number. During the call, users must press *9 to raise their hand or *6 to unmute and state their name and company before asking a question.

Business Overview

Sonata Software operates as an AI-first Modernization Engineering company, leveraging its proprietary Platformation™ framework. The company reported over $1.2 Billion in revenue and employs more than 6,400 AI Engineers. Its services span Cloud, Data, AI, Dynamics, Test Automation, and Managed Services, supported by the Harmoni.AI Enterprise Platform. This platform includes Agent Bridge for governance, Agent Builder for development, and the Agent Marketplace for modular agents.

Headquartered in Bengaluru, Sonata Software maintains a global presence across the US, UK, India, Malaysia, Mexico, Australia, Germany, Switzerland, and Finland. The company serves Fortune 500 clients in Banking, Financial Services and Insurance; Healthcare and Lifesciences; Telecom, Media, and Technology; and Retail, Manufacturing and Distribution. It holds AWS Premier Tier Status and collaborates with partners including Microsoft, AWS, Salesforce, and Snowflake.

Historical Stock Returns for Sonata Software

1 Day5 Days1 Month6 Months1 Year5 Years
-2.71%-6.85%+3.59%+10.48%-21.74%-9.40%

How might Sonata Software's emphasis on its proprietary Platformation™ framework influence its gross margins compared to traditional IT services peers in the upcoming quarter?

What specific growth metrics for the Harmoni.AI Enterprise Platform should investors monitor to gauge the success of the company's 'AI-first' strategic pivot?

Could the recent expansion of global operations in Europe and Mexico signal a shift in revenue mix away from traditional US-centric contracts?

SONATA launches doctor-led preventive healthcare membership

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

SONATA has launched a doctor-led preventive healthcare membership in New York, San Francisco, and Los Angeles, priced at $2,500 annually. The service features deep clinical testing, including whole-genome sequencing and biomarker analysis, integrated with clinical AI and care from board-certified physicians. The company is backed by investors including Lux Capital and Box Group.

powered bylight_fuzz_icon
45579724

*this image is generated using AI for illustrative purposes only.

SONATA has launched a doctor-led preventive healthcare membership in New York, San Francisco, and Los Angeles. The service integrates deep biological testing, board-certified physicians, and clinical AI to create personalized care plans aimed at identifying health risks before disease onset. The founding membership is priced at $2,500 annually.

The membership model addresses the gap between abundant health data and the lack of clinical guidance to interpret it. SONATA performs deep clinical testing not typically included in routine primary care, such as whole-genome sequencing and DNA methylation analysis, and combines these results with a member's medical history and wearable data.

Membership Features

SONATA's offering includes a range of diagnostic and monitoring services designed to provide a comprehensive view of a member's health. The care model is continuous rather than a one-time test, with plans that evolve as a member's biology and goals change.

Feature Description
Physician Access Unlimited visits with a physician-led care team
Testing In-home blood testing and more than 140 blood biomarkers
Genomics Whole-genome sequencing and polygenic risk analysis
Epigenetics DNA methylation analysis and biological age measurement
Integration Wearable and health-record data integration

Technology and Care Model

SONATA utilizes clinical AI developed in-house to synthesize complex information across genomics, biomarkers, medical history, and ongoing care trends. While the AI assists in data processing, all clinical decisions, including interpretation, diagnosis, and prescribing, remain physician-led.

"Modern medicine is built on population averages, but no individual is the average," said David Deng, co-founder and CTO of SONATA. "SONATA's clinical AI synthesizes each member's genomics, epigenetics, biomarkers, and health records against clinical guidelines and the latest peer-reviewed research, so physicians can focus their time on listening to patients and building truly personalized care plans."

The company was co-founded by Sagan Schultz, MD, MBA, and David Deng. Schultz is a former McKinsey healthcare consultant and the first product manager at Linear, while Deng was a first-10 engineer at Ramp and a former member of the clinical genomics team at Flatiron Health. SONATA is backed by Lux Capital, Box Group, and Sunflower Capital.

Historical Stock Returns for Sonata Software

1 Day5 Days1 Month6 Months1 Year5 Years
-2.71%-6.85%+3.59%+10.48%-21.74%-9.40%

Does SONATA plan to expand its services beyond New York, San Francisco, and Los Angeles in the near future?

How will SONATA navigate regulatory challenges regarding the use of clinical AI in diagnostics and prescribing?

What are the potential barriers to widespread adoption given the $2,500 annual price point?

More News on Sonata Software

1 Year Returns:-21.74%